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Olsson and Norrby clearly pointed out that estimation
of iron contents in various compartment of the body is a
difficult exercise in which often older literature is the
basis of discussion. We agree that putative knowledge
still needs critical reading before it is presented in new
overviews. Their remarks concern the estimation of iron
contents in erythrocytes and the body stores.
Figure 1 illustrating the major storage sites in our
review is based on the information reported by
Andrews1 and Hentze et al.2 Indeed, the indicated iron
contents of 1800 mg in the erythrocytes results in an
anemic hemoglobin level of 10.6 g/dL (6.6 mmol/L). We
agree that a corrected level of 2500 mg (hemoglobin 14.8
g/dL; 9.2 mmol/L) could be a better reference value.3-6
Estimation of the body iron store turns out to be more
complicated. The statement of Olsson and Norrby that
our figure represented a patient with elevated iron stor-
age is possibly premature. In our opinion three factors
must be kept in mind when it comes to interpretation of
iron stores.
First, one has to be sure what is meant by the term iron
stores. It is not only liver iron (about 1000 mg),1-4,7 but
rather the sum of liver iron, bone marrow, and reticulo-
endothelial macrophages (about 1900 mg) which almost
doubles the amount.
Second, what model is used to calculate body iron
store? A rule of thumb that is often used in clinical prac-
tice describes that 1 µg/L serum ferritin represents 10 mg
body iron4 and is likely based on phlebotomy studies
published by Walters et al. in 1973.8 As a result, current-
ly accepted reference values for serum ferritin ranging
from 20 to 250 µg/L9 represent 200 to 2500 mg body iron
which fits with the iron stores in our figure. Next, Cook et
al.10 reported a serum ferritin-based calculation on 2,800
samples extracted from the NHANES II survey which
results in body iron values ranging from 88 to 527 mg
which is much lower compared to the values we depict-
ed.
Further improvement of this method by integration of
serum transferrin receptor values11 measured in a subset
of samples extracted from the NHANES III survey result-
ed in averaged body iron stores of 776±313 mg (±1 SD)
in men which is higher than in previous studies. A third
factor is the use of different methods and lack of stan-
dardization in ferritin and serum transferrin receptor
analysis, due to the lack of a common standard and the
use of diverse antibodies.12,13 These aforementioned three
factors illustrate the complexity and limits when results
from different studies are compared or even referred to,
especially those performed in the early 70’s where fer-
ritin measurement made its entry in the clinical laborato-
ry. They also show that basal knowledge lacks clear con-
sensus which might lead to false interpretations.
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